CompoAtlas

Alphalarm

Food supplement declared in France, declaration No 2019-10-192

Alphalarm is a food supplement declared in France. Status: retiré du marché le 1 October 2023. 1 point in its composition requires a check (prohibited substance, dose or novel food). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
Laboratoire Densmore Belgium
Status
Retiré du marché le 1 October 2023
Form
Capsule
Daily dose
1 capsule
Directions for use
1 capsule par jour à avaler au cours d'un repas, pendant 2 à 6 mois renouvelable.
Intended populations
Personnes de plus de 60 ans, Homme, Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous antidiabétiques
Objectives stated by the manufacturer (these are not authorised claims)
Œil / Vision

Declaration 290677, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Borago officinalis L.Graine (huile)Pression à froid213 mg
Tagetes erecta L.FleurExtrait fluide alcoolique25 mg

Other active ingredients

NamePer day
Huile de poissonnot declared
Acide lipoïquenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
D-alpha-tocophérolVitamine E300 mg30 mg
Sulfate de zincZinc25 mg15 mg

Additives

E422, E901, E141

Other ingredients

Gélatine de poisson

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé chez les diabétiques, ainsi que les femmes enceintes et allaitantes.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line